Literature DB >> 12923888

Piecemeal degranulation as a general secretory mechanism?

Enrico Crivellato1, Beatrice Nico, Franco Mallardi, Carlo Alberto Beltrami, Domenico Ribatti.   

Abstract

In this article we review the ultrastructural findings, functional aspects, and biological significance of piecemeal degranulation (PMD), a unique secretory pathway that has been described in basophils, mast cells, and eosinophils. Recent ultrastructural data suggestive of PMD in enteroendocrine cells of the gastrointestinal tract and chromaffin cells of the adrenal medulla are also presented and discussed. Further research on PMD in secretory cells of the endocrine and exocrine glands, as well as in neurons, is recommended, since the current data indicate that PMD has a broader spectrum of expression than was hitherto reported. The identification of the PMD phenotype in different cell types (e.g., basophils, mast cells, eosinophils, enteroendocrine cells, and adrenal chromaffin cells) suggests that PMD is a unique degranulation model for paracrine and endocrine secretion. Further investigation will clarify whether PMD can be considered as a general mechanism for the slow release of bioactive stored materials by granulated secretory cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12923888     DOI: 10.1002/ar.a.10095

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  23 in total

Review 1.  Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.

Authors:  Rossana C N Melo; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

2.  Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients.

Authors:  A Malbrán; E Yeyati; G L Rey; N Galassi
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  SNAP23-Dependent Surface Translocation of Leukotriene B4 (LTB4) Receptor 1 Is Essential for NOX2-Mediated Exocytotic Degranulation in Human Mast Cells Induced by Trichomonas vaginalis-Secreted LTB4.

Authors:  Arim Min; Young Ah Lee; Kyeong Ah Kim; Jamel El-Benna; Myeong Heon Shin
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Authors:  Rossana C N Melo; Sandra A C Perez; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

5.  Piecemeal degranulation in human tumour pheochromocytes.

Authors:  Enrico Crivellato; Nicoletta Finato; Domenico Ribatti; Carlo Alberto Beltrami
Journal:  J Anat       Date:  2005-01       Impact factor: 2.610

Review 6.  Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Histol Histopathol       Date:  2010-10       Impact factor: 2.303

7.  Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.

Authors:  Ke Zhang; Jeffrey Liu; Thao Truong; Elyssa Zukin; Wendy Chen; Andrew Saxon
Journal:  J Immunol       Date:  2017-04-10       Impact factor: 5.422

8.  High-resolution three-dimensional imaging of the rich membrane structures of bone marrow-derived mast cells.

Authors:  T Zink; Z Deng; H Chen; L Yu; F T Liu; G Y Liu
Journal:  Ultramicroscopy       Date:  2008-08-06       Impact factor: 2.689

Review 9.  Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

Authors:  Fabrice Tolle; Viktor Umansky; Jochen Utikal; Stephanie Kreis; Sabrina Bréchard
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

10.  Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.

Authors:  Neil Martin; Andrew Ruddick; Greer K Arthur; Heidi Wan; Lucy Woodman; Christopher E Brightling; Don J L Jones; Ian D Pavord; Peter Bradding
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.